Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
A case of rhino-orbito-cerebral mucormycosis is presented showing its aggressive nature and progression of disease. The typical clinical features, neuroimaging and histological findings are highlighted in this report. Amphotericin B and surgical debridement remain the mainstay of treatment. However, associated co-morbidities need to be addressed.
Jeevanan
J
J
Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur.
Gendeh
B S
BS
Faridah
H A
HA
Vikneswaran
T
T
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001927:Brain Diseases / Q000382:microbiology; D003646:Debridement; D018450:Disease Progression; D015821:Eye Infections, Fungal / Q000175:diagnosis* / Q000382:microbiology / Q000601:surgery*; D006801:Humans; D016867:Immunocompromised Host; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D009668:Nose Diseases / Q000382:microbiology; D009916:Orbital Diseases / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B